Menu
  • Sun pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.

    Sun pharma plans gradual phase-out of Ranbaxy-branded drugs in U.S.

    Attachment File: Download (27.28 KB) pdf
  • SEBI to proble share movements in Ranbaxy

    SEBI to proble share movements in Ranbaxy

    Attachment File: Download (54.67 KB) pdf
  • Rs. 8900-cr rich Piramal not eying new areas

    Rs. 8900-cr rich Piramal not eyeing new areas

    Attachment File: Download (69.35 KB) pdf
  • Sun Pharmas behind-the -scenes chief

    Sun Pharma;s behind-the -scenes chief

    Attachment File: Download (88.82 KB) pdf
  • SEBI queries Sun on Ranbaxy deal

    SEBI queries Sun on Ranbaxy deal

    Attachment File: Download (34.12 KB) pdf
  • Astra Zeneca Pharma fixes floor price for delisting at Rs. 854

    Astra Zeneca Pharma fixes floor price for delisting at Rs. 854

    Attachment File: Download (25.82 KB) pdf
  • Pollution woes: No relief yet for Dr. Reddys ingredients unit

    Pollution woes: No relief yet for Dr. Reddy's ingredients unit

    Attachment File: Download (74.47 KB) pdf
  • Sun takes a shine to Ranbaxy

    Sun takes a shine to Ranbaxy

    Attachment File: Download (73.01 KB) pdf
  • We would like to keep the Ranbaxy brand alive in most markets

    We would like to keep the Ranbaxy brand alive in most markets'

    Attachment File: Download (54.41 KB) pdf
  • The rising sun

    The rising sun

    Attachment File: Download (134.36 KB) pdf

Pages